Figure 2:
Schematic of main vascular compartments, blood-brain barrier (BBB), and their potential changes in OUD. These changes can be caused directly by actions of self-administered mu-opioid receptor (MOP-r) agonists on immune cells and by neuroendocrine changes in the stress axis (e.g., affecting cortisol levels and its diverse downstream targets).